BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

curasan AG (DX:CUR) and TransCorp Spine Inc. Sign Supply Agreement for the US-Market


1/11/2011 10:40:01 AM

Kleinostheim, Germany, 11th January 2011 – curasan Inc., the north American subsidiary of exchange listed curasan AG, Germany, (ISIN: DE 000 549 453 8), has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb® Ortho block forms used to repair vertebral bone channels created during surgeries to decompress neural tissue in the spine.

These block forms may be used in conjunction with surgical technique and an in- strument system designed by TransCorp Spine Inc. that allows surgeons to achieve decompression of the cervical spine while maintaining the intervertebral disc. It is estimated that up to 40% of cervical decompressions could be treated with this technique. Initial clinical results show excellent outcomes. TransCorp Spine Inc. plans to commercialize the system in 2011.

About TransCorp Spine Inc.

TransCorp Spine Inc. is a privately held company dedicated to developing unique, commer- cially viable, minimally invasive, and tissue saving products and procedures for the treatment of compressions in the Cervical Spine. TransCorp Spine Inc. products are designed to enable the surgeon to rapidly, safely and effectively decompress the cervical spine without the need to perform a diskectomy, fusion or arthroplasty. www.transcorpspine.com

About curasan AG:

Exchange listed curasan AG (ISIN: DE 000 549 453 8) is one of the leading firms in the field of regenerative medicine especially in bone and tissue regeneration. In addition to the syn- thetic Cerasorb® bone substitution and regeneration material, the company has developed a future-oriented product pipeline, which will be ready for market rollout within the next few years via well-positioned contractual partners in various market segments. www.curasan.com

Press Contact: curasan AG Andrea Weidner Tel. +49 (0)6027 40 900-51 Fax +49 (0)6027 40 900-39 andrea.weidner@curasan.de www.curasan.de

fr financial relations gmbh Jörn Gleisner Tel. +49 (0)69 95 90 83 20 Fax +49 (0)69 95 90 83 99 j.gleisner@finanical-relations.de



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES